title: Understanding MIH: definition, epidemiology, differential diagnosis and new treatment guidelines.
abstract: Molar-Incisor Hypomineralisation (MIH) is a congenital disease which increases in prevalence. It affects permanent first molars and, often to a lesser degree, permanent incisors with variable severity. The aetiology is unknown, but different hypotheses have been advanced. Differential diagnosis is mandatory not to confound MIH with other diseases. Treatment consists in a minimally invasive approach by reinforcing and protecting the existing dental structure. In more severe cases, restorative treatment may be indicated.
authors.affiliation: Division of Cariology and Endodontology, University of Geneva, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Mast
authors.forename: M T
authors.initials: MT
authors.lastname: Rodrigueztapia
authors.forename: L
authors.initials: L
authors.lastname: Daeniker
authors.forename: I
authors.initials: I
authors.lastname: Krejci
mesh_terms: D000567:Amelogenesis Imperfecta / Q000175:diagnosis; D002327:Cariostatic Agents / Q000627:therapeutic use; D002364:Caseins / Q000627:therapeutic use; D002985:Clinical Protocols; D003743:Dental Enamel / Q000473:pathology; D003744:Dental Enamel Hypoplasia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D003937:Diagnosis, Differential; D005260:Female; D005459:Fluorides / Q000627:therapeutic use; D005460:Fluorides, Topical / Q000627:therapeutic use; D005899:Glass Ionomer Cements / Q000737:chemistry; D006801:Humans; D007180:Incisor / Q000473:pathology; D007231:Infant, Newborn; D019458:Insurance Coverage / Q000331:legislation & jurisprudence; D007348:Insurance, Health / Q000331:legislation & jurisprudence; D008963:Molar / Q000473:pathology; D013557:Switzerland
chemical_list: D002327:Cariostatic Agents; D002364:Caseins; D005460:Fluorides, Topical; D005899:Glass Ionomer Cements; C447032:casein phosphopeptide-amorphous calcium phosphate nanocomplex; D005459:Fluorides